NCT00193700View on ClinicalTrials.gov

Pharmacokinetic Evaluation of Testosterone Gel (1%)

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2002

Conditions
Primary or Secondary HypogonadismConstitutional Delay in Growth and Puberty (CDGP)
Interventions
DRUG

Testosterone Gel (1%)

Trial Locations (9)

Unknown

Site 208, Birmingham

Site 203, Torrance

Site 204, Jacksonville

Site 201, Kansas City

Site 206, Morristown

Site 207, Brooklyn

Site 209, Cincinnati

Site 202, Philadelphia

Site 205, Seattle

All Listed Sponsors
collaborator

Unimed Pharmaceuticals

INDUSTRY

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00193700 - Pharmacokinetic Evaluation of Testosterone Gel (1%) | Biotech Hunter | Biotech Hunter